Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Assets (2016 - 2025)

Fennec Pharmaceuticals filings provide 15 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, down 1.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for Fennec Pharmaceuticals, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2024 to a low of 0.01% in Q2 2023.
  • Median Return on Assets over the past 5 years was 0.01% (2022), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Assets: decreased -1bps in 2023 and later rose 1bps in 2024.
  • Fennec Pharmaceuticals' Return on Assets stood at 0.01% in 2021, then plummeted by -52bps to 0.01% in 2022, then increased by 18bps to 0.01% in 2023, then surged by 101bps to 0.0% in 2024, then crashed by -1445bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.